Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (651-660 of 903) with videos related to

Pageof 91
Sort By:
BMC Neurology|November 26, 2016
A profile of The Clinical Course of Cognition and Comorbidity in Mild Cognitive Impairment and Dementia Study (The 4C study): two complementary longitudinal, clinical cohorts in the NetherlandsWeiqi Liao, Renske E G Hamel, Marcel G M Olde Rikkert, et al.
Journal of Neurology|November 27, 2012
Cerebral white matter changes are associated with abnormalities on neurological examination in non-disabled elderly: the LADIS studyAnna Poggesi, Alida Gouw, Wiesje van der Flier, et al.
Annals of Neurology|February 14, 2021
Onset of Preclinical Alzheimer Disease in Monozygotic TwinsElles Konijnenberg, Jori Tomassen, Anouk den Braber, et al.
Journal of Neurology|April 12, 2014
Neurological abnormalities predict disability: the LADIS (Leukoaraiosis And DISability) studyAnna Poggesi, Alida Gouw, Wiesje van der Flier, et al.
Journal of Alzheimer'S Disease : JAD|July 7, 2012
Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trialPhilip Scheltens, Jos W R Twisk, Rafael Blesa, et al.
Alzheimer'S Research & Therapy|October 12, 2021
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services-part 2 of 6Janice M Ranson, Timothy Rittman, Shabina Hayat, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2020
Correction to: Regional [<sup>18</sup>F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's diseaseEmma E Wolters, Rik Ossenkoppele, Sander C J Verfaillie, et al.
Acta Neuropathologica|December 8, 2022
Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathiesFrederique J Hart de Ruyter, Tjado H J Morrema, Jurre den Haan, et al.
Journal of Alzheimer'S Disease : JAD|July 26, 2021
Genetics Contributes to Concomitant Pathology and Clinical Presentation in Dementia with Lewy BodiesSven J van der Lee, Inger van Steenoven, Marleen van de Beek, et al.
Stroke|March 6, 2010
Diffusion-weighted imaging and cognition in the leukoariosis and disability in the elderly studyReinhold Schmidt, Stefan Ropele, José Ferro, et al.
Pageof 91

Showing results (651-660 of 903) with videos related to

Sort By:
Pageof 91
BMC Neurology|November 26, 2016
A profile of The Clinical Course of Cognition and Comorbidity in Mild Cognitive Impairment and Dementia Study (The 4C study): two complementary longitudinal, clinical cohorts in the NetherlandsWeiqi Liao, Renske E G Hamel, Marcel G M Olde Rikkert, et al.
Journal of Neurology|November 27, 2012
Cerebral white matter changes are associated with abnormalities on neurological examination in non-disabled elderly: the LADIS studyAnna Poggesi, Alida Gouw, Wiesje van der Flier, et al.
Annals of Neurology|February 14, 2021
Onset of Preclinical Alzheimer Disease in Monozygotic TwinsElles Konijnenberg, Jori Tomassen, Anouk den Braber, et al.
Journal of Neurology|April 12, 2014
Neurological abnormalities predict disability: the LADIS (Leukoaraiosis And DISability) studyAnna Poggesi, Alida Gouw, Wiesje van der Flier, et al.
Journal of Alzheimer'S Disease : JAD|July 7, 2012
Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trialPhilip Scheltens, Jos W R Twisk, Rafael Blesa, et al.
Alzheimer'S Research & Therapy|October 12, 2021
Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services-part 2 of 6Janice M Ranson, Timothy Rittman, Shabina Hayat, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2020
Correction to: Regional [<sup>18</sup>F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's diseaseEmma E Wolters, Rik Ossenkoppele, Sander C J Verfaillie, et al.
Acta Neuropathologica|December 8, 2022
Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathiesFrederique J Hart de Ruyter, Tjado H J Morrema, Jurre den Haan, et al.
Journal of Alzheimer'S Disease : JAD|July 26, 2021
Genetics Contributes to Concomitant Pathology and Clinical Presentation in Dementia with Lewy BodiesSven J van der Lee, Inger van Steenoven, Marleen van de Beek, et al.
Stroke|March 6, 2010
Diffusion-weighted imaging and cognition in the leukoariosis and disability in the elderly studyReinhold Schmidt, Stefan Ropele, José Ferro, et al.
Pageof 91